Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthequity (HQY) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to $51.7 million.

  • Healthequity's Net Income towards Common Stockholders rose 80640.01% to $51.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $191.8 million, marking a year-over-year increase of 9836.2%. This contributed to the annual value of $96.7 million for FY2025, which is 7357.66% up from last year.
  • According to the latest figures from Q4 2025, Healthequity's Net Income towards Common Stockholders is $51.7 million, which was up 80640.01% from $59.8 million recorded in Q3 2025.
  • Healthequity's Net Income towards Common Stockholders' 5-year high stood at $59.8 million during Q3 2025, with a 5-year trough of -$32.8 million in Q1 2022.
  • Its 5-year average for Net Income towards Common Stockholders is $12.6 million, with a median of $5.5 million in 2021.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first crashed by 247972.97% in 2021, then soared by 1271435.41% in 2024.
  • Over the past 5 years, Healthequity's Net Income towards Common Stockholders (Quarter) stood at -$5.0 million in 2021, then soared by 67.43% to -$1.6 million in 2022, then surged by 994.15% to $14.7 million in 2023, then plummeted by 61.13% to $5.7 million in 2024, then surged by 806.4% to $51.7 million in 2025.
  • Its Net Income towards Common Stockholders was $51.7 million in Q4 2025, compared to $59.8 million in Q3 2025 and $53.9 million in Q2 2025.